EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploratory Metabolomic and Lipidomic Profiling in a Manganese-Exposed Parkinsonism-Affected Population in Northern Italy

Freeman Lewis iD, Daniel Shoieb, Somaiyeh Azmoun, Elena Colicino, Yan Jin, Jinhua Chi, Hari Krishnamurthy iD, Donatella Placidi iD, Alessandro Padovani, Andrea Pilotto, Fulvio Pepe, Marinella Tula und 4 weitere

Metabolites · 20.07.2025 · 15 (7) · 487

DOI: 10.3390/metabo15070487 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Metabolites, online erschienen am 20.07.2025. Verfasst von Freeman Lewis und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental Health Sciences, Florida International University, Miami, FL 33199, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, INAIL, NIEHS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Chronic manganese (Mn) exposure is a recognized environmental contributor to Parkinsonian syndromes, including Mn-induced Parkinsonism (MnIP). This study aimed to evaluate whole-blood Mn levels and investigate disease/exposure-status-related alterations in metabolomic and lipidomic profiles.

Methods

A case–control study (N = 97) was conducted in Brescia, Italy, stratifying participants by Parkinsonism diagnosis and residential Mn exposure. Whole-blood Mn was quantified using ICP-MS. Untargeted metabolomic and lipidomic profiling was conducted using LC-MS. Statistical analyses included Mann–Whitney U tests, conditional logistic regression, ANCOVA, and pathway analysis.

Results

Whole-blood Mn levels were significantly elevated in Parkinsonism cases vs. controls (median: 1.55 µg/dL [IQR: 0.75] vs. 1.02 µg/dL [IQR: 0.37]; p = 0.001), with Mn associated with increased odds of Parkinsonism (OR = 2.42, 95% CI: 1.13–5.17; p = 0.022). The disease effect metabolites included 3-sulfoxy-L-tyrosine (β = 1.12), formiminoglutamic acid (β = 0.99), and glyoxylic acid (β = 0.83); all FDR p < 0.001. The exposure effect was associated with elevated glycocholic acid (β = 0.51; FDR p = 0.006) and disrupted butanoate (Impact = 0.03; p = 0.004) and glutamate metabolism (p = 0.03). Additionally, SLC-mediated transmembrane transport was enriched (p = 0.003). The interaction effect identified palmitelaidic acid (β = 0.30; FDR p < 0.001), vitamin B6 metabolism (Impact = 0.08; p = 0.03), and glucose homeostasis pathways. In lipidomics, triacylglycerols and phosphatidylethanolamines were associated with the disease effect (e.g., TG(16:0_10:0_18:1), β = 0.79; FDR p < 0.01). Ferroptosis and endocannabinoid signaling were enriched in both disease and interaction effects, while sphingolipid metabolism was specific to the interaction effect.

Conclusions

Mn exposure and Parkinsonism are associated with distinct metabolic and lipidomic perturbations. These findings support the utility of omics in identifying environmentally linked Parkinsonism biomarkers and mechanisms.

Schlagwörter

Stichwörter der Autor:innen

Parkinsonismbiomonitoringenvironmental neurotoxicologylipidomicsmanganese exposuremetabolomics

Autor:innen und Institutionen

  • Department of Environmental Health Sciences, Florida International University, Miami, FL 33199, USA.
  • Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, 25123 Brescia, Italy.
  • Department of Environmental Medicine and Climate Science, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Department of Biomedical Engineering, Vibrant Sciences LLC., San Carlos, CA 95054, USA.
  • Department of Clinical and Experimental Sciences, University of Brescia, 25123 Brescia, Italy.
  • Clinic of Neurology, Poliambulanza Foundation, 25124 Brescia, Italy.

ORCID-Profile: Freeman Lewis, Hari Krishnamurthy, Donatella Placidi, Roberto Lucchini

Förderung

  • NIH HHS
  • INAIL
  • NIEHS NIH HHS
  • European Union Sixth Framework Program
  • National Institute of Health
  • National Institute of Environmental Health Sciences
  • The Italian Work Compensation Institute

Zitieren

APA

Lewis, F., Shoieb, D., Azmoun, S., Colicino, E., Jin, Y., Chi, J., Krishnamurthy, H., Placidi, D., Padovani, A., Pilotto, A., Pepe, F., Tula, M., Crippa, P., Wang, X., Gu, H., & Lucchini, R. (2025). Exploratory Metabolomic and Lipidomic Profiling in a Manganese-Exposed Parkinsonism-Affected Population in Northern Italy. Metabolites, 15(7), 487. https://doi.org/10.3390/metabo15070487

Vancouver

Lewis F, Shoieb D, Azmoun S, Colicino E, Jin Y, Chi J, et al. Exploratory Metabolomic and Lipidomic Profiling in a Manganese-Exposed Parkinsonism-Affected Population in Northern Italy. Metabolites. 2025;15(7):487. doi:10.3390/metabo15070487

BibTeX
@article{Lewis2025,
  author = {Lewis, Freeman and Shoieb, Daniel and Azmoun, Somaiyeh and Colicino, Elena and Jin, Yan and Chi, Jinhua and Krishnamurthy, Hari and Placidi, Donatella and Padovani, Alessandro and Pilotto, Andrea and Pepe, Fulvio and Tula, Marinella and Crippa, Patrizia and Wang, Xuexia and Gu, Haiwei and Lucchini, Roberto},
  title = {Exploratory Metabolomic and Lipidomic Profiling in a Manganese-Exposed Parkinsonism-Affected Population in Northern Italy},
  journal = {Metabolites},
  year = {2025},
  volume = {15},
  number = {7},
  pages = {487},
  doi = {10.3390/metabo15070487}
}
Kostenlos starten →